ImmunoVec
PrivateLast Round
Seed Round
Jul 14, 2026
Total Funding Raised
$56.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmunoVec is a biotechnology company developing a platform for in-vivo cell engineering to create therapies for autoimmune diseases, solid tumors, and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoVec Comparables
Compare ImmunoVec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alaya.bio | 84% | |
| AbbVie | 84% | |
| Aera Therapeutics | 79% | |
ImmunoVec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 14, 2026 | ||||
| Series A | Oct 8, 2025 | ||||
| Grant | Oct 8, 2025 | ||||
| Grant | May 29, 2025 | ||||
| Seed | Mar 2, 2022 | ||||
Grant | Dec 2, 2021 |
Key People
Founding team and executive leadership
ImmunoVec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Constellar Ventures | Seed |
| California Institute for Regenerative Medicine | Grant |
| Anthem Venture Partners | Seed, Series A |
| ARPA-H | Grant |
| Onelin Capital Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
$41M grant awarded by ARPA-H
- Oct 8, 2025
Raised Series A with Anthem Venture Partners
ImmunoVec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoVec's valuation, stock price, and market status.